Results

Total Results: 1,310 records

Showing results for "estimating".

101. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
     February 18, 2020 - Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force T he US Preventi…

102. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
     May 15, 2004 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Review Ovarian Cancer: Screening, May 2004 May 15, 2004 Recommendations made by the USPSTF are independent of the U.S. government. They should no…

103. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screeni
     July 05, 2005 - We used the results of the evidence review to construct an outcomes table estimating the effects of one-time … safely discontinue prophylaxis against certain opportunistic infections. 17 We identified no studies estimating … Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence

104. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
     July 05, 2005 - We used the results of the evidence review to construct an outcomes table estimating the effects of one-time … safely discontinue prophylaxis against certain opportunistic infections. 17 We identified no studies estimating … Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence

105. Archived: Breast Cancer: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-1996
     January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Breast Cancer: Screening, 1996 January 01, 1996 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

106. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
     August 23, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication August 23, 2022 Recommendations made by the USPSTF are indepe…

107. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r3f2G_ReqS8tN48szHPCxt
     November 01, 2009 - These models are ideally suited for estimating the effect of screening under a variety of policies (6 … Third, in estimating lifetime results, we projected breast cancer trends from background incidence rates

108. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
     June 11, 2019 - Estimating per-act HIV transmission risk: a systematic review.

109. Archived: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     September 09, 2014 - Sensitivity analyses using an alternate method for estimating pooled random effects resulted in similar

110. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
     June 20, 2019 - We used the results of the evidence review to construct an outcomes table estimating the effects of one-time … We identified no studies estimating the effects of screening or treatment on the proportion of patients … Validity of indirect compar- ison for estimating efficacy of competing interventions: empirical evidence

111. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - Estimating per-act HIV transmission risk: a systematic review. AIDS . 2014;28(10):1509-1519. 6.

112. Procedure Manual Section 5. Modeling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-section-5-modeling
     July 05, 2017 - Procedure Manual Section 5. Modeling In addition to systematic reviews, the Task Force uses modeling to inform the recomme…

113. Procedure Manual Section 5. Modeling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-5-modeling
     July 05, 2017 - Procedure Manual Section 5. Modeling Share to Facebook Share to X Share to WhatsApp Share to Email Print In addition to systematic reviews, the Task Force uses modeling to inform the recommendation process. The Task Force uses modeling only w…

114. Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
     March 09, 2021 - Screening Trial [PLCOm2012], the Lung Cancer Death Risk Assessment Tool [LCDRAT], and Kovalchik model) estimating … Follow-up Study, the HUNT Lung Cancer model, LCDRAT, COPD-LUCSS [Lung Cancer Screening Score], Kovalchik) estimating … Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.

115. Recommendation: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
     March 02, 2020 - Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016.

116. Recommendation: Thyroid Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-cancer-screening
     May 09, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Thyroid Cancer: Screening May 09, 2017 Recommendations made by the USPSTF are independent of the U.S. government. They should not be cons…

117. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
     December 01, 2015 - Modeling makes a useful contribution to estimating overdiagnosis since it explicitly considers lead-time … This method of estimating overdiagnosis was compared to the difference between total number of diagnosed … While all CISNET models have adopted a new APC model as the basis for estimating breast cancer incidence … This process is repeated many times to accumulate enough acceptances to allow for adequately estimating … Modeling makes a useful contribution to estimating overdiagnosis since it explicitly considers lead-time

118. Final Evidence Summary: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document19468/tobacco-and-nicotine-use-prevention-in-children-and-adolescents-primary-care-interventions
     April 28, 2020 - . f Baseline smokers were excluded from the analysis (specific numbers not reported). g Generalized estimating

119. Recommendation: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication
     January 29, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication January 29, 2019 Recommendations made by the USPSTF are indepe…

120. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - Modeling makes a useful contribution to estimating overdiagnosis since it explicitly considers lead-time … This method of estimating overdiagnosis was compared to the difference between total number of diagnosed … While all CISNET models have adopted a new APC model as the basis for estimating breast cancer incidence … This process is repeated many times to accumulate enough acceptances to allow for adequately estimating … Modeling makes a useful contribution to estimating overdiagnosis since it explicitly considers lead-time